Literature DB >> 21119415

Controversies in skull reconstruction.

James E Zins1, Claude-Jean Langevin, Serdar Nasir.   

Abstract

In the early 1980s, it was shown that bone from the skull (membranous bone) maintained its volume to a significantly greater extent than bone from the rib and iliac crest regions (endochondral bone). However, the reason for this enhanced volume maintenance was not clarified for many years. On the basis of this enhanced volume maintenance, cranial bone became the ideal autogenous graft of choice for hard tissue repair. In the ensuing years, the current authors performed a large number of autogenous split skull cranial bone cranioplasties with significant success. However, the lure of an off-the-shelf material that obviates bone harvest remained. From 1995 to 2005, the senior author performed 20 full-thickness skull defect cranioplasty corrections using calcium phosphate cement (Norian Craniofacial Repair System; Synthes, Inc, West Chester, PA; Stryker-Leibinger, Kalamazoo, MI). Of these full-thickness defects, 16 were large (arbitrarily defined as greater than 25 cm2). In this paper, we report our long-term major and minor complication rates using this material. Because of our high, long-term complication rate (38%), we believe this material is contraindicated for large, full-thickness, skull defects (>25 cm2) and we have returned to autogenous cranial bone as the criterion standard for reconstruction in such patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21119415     DOI: 10.1097/SCS.0b013e3181c34675

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  13 in total

Review 1.  Bioinspired Collagen Scaffolds in Cranial Bone Regeneration: From Bedside to Bench.

Authors:  Justine C Lee; Elizabeth J Volpicelli
Journal:  Adv Healthc Mater       Date:  2017-06-06       Impact factor: 9.933

Review 2.  Concise review: personalized human bone grafts for reconstructing head and face.

Authors:  Sarindr Bhumiratana; Gordana Vunjak-Novakovic
Journal:  Stem Cells Transl Med       Date:  2011-12-07       Impact factor: 6.940

3.  The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications.

Authors:  Athanassios Kyrgidis; Thrasivoulos-George Tzellos; Konstantinos Toulis; Konstantinos Antoniades
Journal:  J Osteoporos       Date:  2011-02-16

4.  Cranioplasty: Review of materials and techniques.

Authors:  Seckin Aydin; Baris Kucukyuruk; Bashar Abuzayed; Sabri Aydin; Galip Zihni Sanus
Journal:  J Neurosci Rural Pract       Date:  2011-07

5.  Calvarial reconstruction using high-density porous polyethylene cranial hemispheres.

Authors:  Nitin J Mokal; Mahinoor F Desai
Journal:  Indian J Plast Surg       Date:  2011-09

Review 6.  Complications after craniofacial reconstruction with calcium phosphate cements: a case report and review of the literature.

Authors:  Fereydoun Pourdanesh; Noorahmad Latifi; Fatemeh Latifi
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2018-10-26

Review 7.  Nanoparticles and Nanostructured Surface Fabrication for Innovative Cranial and Maxillofacial Surgery.

Authors:  Simona Cavalu; Iulian Vasile Antoniac; Aurel Mohan; Florian Bodog; Cristian Doicin; Ileana Mates; Mihaela Ulmeanu; Roman Murzac; Augustin Semenescu
Journal:  Materials (Basel)       Date:  2020-11-27       Impact factor: 3.623

8.  Bioceramic Implant Induces Bone Healing of Cranial Defects.

Authors:  Thomas Engstrand; Lars Kihlström; Kalle Lundgren; Margarita Trobos; Håkan Engqvist; Peter Thomsen
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-08-25

9.  Early resorption of an artificial bone graft made of calcium phosphate for cranioplasty: case report.

Authors:  Bernardo Assumpção de Monaco; Erich Talamoni Fonoff; Manoel Jacobsen Teixeira
Journal:  Neuropsychiatr Dis Treat       Date:  2013-11-15       Impact factor: 2.570

10.  Split Rib Cranioplasty for Frontal Osteoma: A Case Report and Review of the Literature.

Authors:  Vaner Koksal; Selim Kayaci; Recep Bedir
Journal:  Iran Red Crescent Med J       Date:  2016-01-04       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.